Page last updated: 2024-09-05

ezlopitant and (2s,3s)-2-phenyl-3-((5-trifluoromethoxy-2-methoxy)benzylamino)piperidine

ezlopitant has been researched along with (2s,3s)-2-phenyl-3-((5-trifluoromethoxy-2-methoxy)benzylamino)piperidine in 1 studies

Compound Research Comparison

Studies
(ezlopitant)
Trials
(ezlopitant)
Recent Studies (post-2010)
(ezlopitant)
Studies
((2s,3s)-2-phenyl-3-((5-trifluoromethoxy-2-methoxy)benzylamino)piperidine)
Trials
((2s,3s)-2-phenyl-3-((5-trifluoromethoxy-2-methoxy)benzylamino)piperidine)
Recent Studies (post-2010) ((2s,3s)-2-phenyl-3-((5-trifluoromethoxy-2-methoxy)benzylamino)piperidine)
22212832

Protein Interaction Comparison

ProteinTaxonomyezlopitant (IC50)(2s,3s)-2-phenyl-3-((5-trifluoromethoxy-2-methoxy)benzylamino)piperidine (IC50)
Substance-P receptorHomo sapiens (human)0.0002

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujiwara, Y; Kanai, Y; Koike, H; Kusano, R; Mizutani, M; Murata, Y; Naganeo, F; Nukui, S; Sakakibara, A; Satake, K; Shimada, K; Shishido, Y; Suga, O; Tsuchiya, M; Ueda, S; Ueno, N; Wakabayashi, H; Yamagishi, T1

Other Studies

1 other study(ies) available for ezlopitant and (2s,3s)-2-phenyl-3-((5-trifluoromethoxy-2-methoxy)benzylamino)piperidine

ArticleYear
Discovery and stereoselective synthesis of the novel isochroman neurokinin-1 receptor antagonist 'CJ-17,493'.
    Bioorganic & medicinal chemistry, 2008, Aug-01, Volume: 16, Issue:15

    Topics: Animals; Antiemetics; Benzopyrans; Cell Line; Cisplatin; Dose-Response Relationship, Drug; Ferrets; Gerbillinae; Humans; Molecular Structure; Neurokinin-1 Receptor Antagonists; Piperidines; Structure-Activity Relationship; Vomiting

2008